We use cookies to enhance your experience. If you continue browsing, it means you agree to our use of these cookies. For detailed information on how we use cookies, please refer to our cookie policy.
The Aurisco Code of Conduct applies to Aurisco Pharmaceutical Co., Ltd., its branches, subsidiaries, and all employees, serving as binding guidelines for daily operations and supplementing the terms of internal management systems.
The company strictly adheres to Chinese GMP and international cGMP standards, establishing a comprehensive quality management system complying with regulation of China's NMPA,the U.S.FDA, the EU EMA, Brazil's ANVIS and other stringent regulatory authorities. Our production lines have consistently passed inspections from domestic and oversea regulation authorities, as well as regular GMP and EHS audits from customers.
Aurisco consistently adheres to a customer-centric philosophy, focusing on the actual needs and expectations of clients to deliver higher-quality and standardized products and services. The company regards stringent quality assurance and a robust quality control system as a solid foundation for producing superior products.
The company firmly incorporates EHS into its long-term development and economic plans, establishing environmental and occupational health and safety objectives based on legal requirements, significant environmental aspects, and major hazard sources.
We are committed to achieving carbon neutrality by 2030. We plan to increase the proportion of renewable energy and continuously improve our energy structure.
The first Chinese company to pass the RX-360 audit
Aurisco is the first Chinese company to pass the supply chain security audit
